Skip to content

Photon/Proton Radiation Therapy for Carcinoma of the Skin of the Head and Neck

A Clinical Outcomes Protocol of Photon/Proton Beam Radiation Therapy for Carcinoma of the Skin of the Head and Neck With Perineural Invasion

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00797043
Acronym
SK01
Enrollment
11
Registered
2008-11-25
Start date
2008-09-30
Completion date
2015-07-31
Last updated
2017-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Neoplasm of Skin Head and Neck

Keywords

Carcinoma of the skin of the head and neck, Proton radiation, Outcomes

Brief summary

The purpose of this study is to collect information from the questionnaire and your medical records to see what effects the proton radiation has on you and your cancer and collect and analyze morbidity outcomes: Incidence of xerostomia (dry mouth) and tumor control.

Detailed description

Data collection will be obtained from the patient's medical records including initial evaluation, pathology report, dosimetry information, radiotherapy completion records and follow-up.

Interventions

None listed

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Carcinoma of the skin of the head and neck region with incidental or symptomatic perineural invasion. * Biopsy-proven squamous cell carcinoma. * Will receive treatment with proton radiation.

Exclusion criteria

* Evidence of distant metastasis. * Previous irradiation for head and neck cancer.

Design outcomes

Primary

MeasureTime frame
Collect and analyze morbidity outcomes: Incidence of grade 3 or higher xerostomia (dry mouth)1 year following the completion of radiation therapy

Secondary

MeasureTime frame
Collect and analyze tumor control outcomes.When each patient has been followed for a minimum of 6 months and then again at 24 months.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026